FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

20471711000001102: Doxorubicin liposomal pegylated 20mg/10ml solution for infusion vials 1 vial (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-May 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
68991501000001110 Doxorubicin liposomal pegylated 20mg/10ml solution for infusion vials 1 vial (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
68991601000001114 Doxorubicin liposomal pegylated 20mg/10ml solution for infusion vials 1 vial en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Doxorubicin liposomal pegylated 20mg/10ml solution for infusion vials 1 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Doxorubicin liposomal pegylated 20mg/10ml solution for infusion vials 1 vial Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Doxorubicin liposomal pegylated 20mg/10ml solution for infusion vials 1 vial Has VMP Doxorubicin liposomal pegylated 20mg/10ml solution for infusion vials true Inferred relationship Existential restriction modifier
Doxorubicin liposomal pegylated 20mg/10ml solution for infusion vials 1 vial VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Doxorubicin liposomal pegylated 20mg/10ml solution for infusion vials 1 vial VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Doxorubicin liposomal pegylated 20mg/10ml solution for infusion vials 1 vial Has specific active ingredient Doxorubicin hydrochloride liposomal pegylated true Inferred relationship Existential restriction modifier
Doxorubicin liposomal pegylated 20mg/10ml solution for infusion vials 1 vial Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Doxorubicin liposomal pegylated 20mg/10ml solution for infusion vials 1 vial Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Doxorubicin hydrochloride true Inferred relationship Existential restriction modifier
Doxorubicin liposomal pegylated 20mg/10ml solution for infusion vials 1 vial Has basis of strength substance Doxorubicin hydrochloride true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Caelyx pegylated liposomal 20mg/10ml concentrate for solution for infusion vials (Originalis B.V.) 1 vial Is a True Doxorubicin liposomal pegylated 20mg/10ml solution for infusion vials 1 vial Inferred relationship Existential restriction modifier
Caelyx pegylated liposomal 20mg/10ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) 1 vial Is a True Doxorubicin liposomal pegylated 20mg/10ml solution for infusion vials 1 vial Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start